恒瑞医药:不存在按规定应披露而未披露的重大信息
Zheng Quan Ri Bao Wang·2026-02-13 12:46

Core Viewpoint - Heng Rui Medicine (600276) confirmed that its daily operations and business conditions are normal, and there is no significant information that should have been disclosed but was not [1] Group 1 - The company is actively engaging with investors through an interactive platform [1] - The company reassured investors about its operational stability [1] - There are no undisclosed major issues affecting the company's performance [1]

Hengrui Pharma-恒瑞医药:不存在按规定应披露而未披露的重大信息 - Reportify